US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Findit, Inc.

0.0332

0.0000

Volume:- -

Turnover:- -

Market Cap:31.72M

PE:-9.94

High:0.0332

Open:0.0332

Low:0.0332

Close:0.0332

52wk High:0.0332

52wk Low:0.0332

Shares:957.00M

Float Shares:269.49M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0033

EPS(LYR):-0.0021

ROE:-62.65%

ROA:-150.99%

PB:1.86

PE(LYR):-16.05

Loading ...

Overview Company News Filings

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FDIT/filings"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FDIT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FDIT\",,,,,undefined,":{"symbol":"FDIT","market":"US","secType":"STK","nameCN":"Findit, Inc.","latestPrice":0.03315,"timestamp":1778254200000,"preClose":0.03315,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":269490543,"shares":957000000,"eps":-0.003336,"marketStatus":"Trading","change":0,"latestTime":"05-08 11:30:00 EDT Delay","open":0.03315,"high":0.03315,"low":0.03315,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.003336,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778270400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.03315,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FDIT\",,,,,undefined,":{"symbol":"FDIT","floatShares":269490543,"roa":"-150.99%","roe":"-62.65%","lyrEps":-0.002066,"shares":957000000,"dividePrice":0,"high":0.03315,"amplitude":0,"preClose":0.03315,"low":0.03315,"week52Low":0.03315,"pbRate":"1.86","psRate":"-72.89","week52High":0.03315,"institutionHeld":0,"latestPrice":0.03315,"eps":-0.003336,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.003336,"open":0.03315,"prevYearClose":0.03315,"prevWeekClose":0.0331,"prevMonthClose":0.0331,"prevQuarterClose":0.0331,"fiveDayClose":0.0331,"twentyDayClose":0.0331,"sixtyDayClose":0.0331},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FDIT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FDIT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FDIT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"FDIT\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"18397350","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004996-FDIT","pdf_url":"","pub_time":1721689297000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"FDIT","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-004996-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004996/bioregenx_8k.htm","primary":true,"translateUrl":"","linkName":"bioregenx_8k.htm","type":"8-K","id":"NTFILEGBujBe2mh4mFvFsm","market":"us","size":18702}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-07-23 07:01","pubTimestamp":1721689297,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18532452","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004992-FDIT","pdf_url":"","pub_time":1721682349000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"FDIT","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-004992-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004992/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8v6S83rVQpvYpUuJ","market":"us","size":8509}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-07-23 05:05","pubTimestamp":1721682349,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18392670","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004990-FDIT","pdf_url":"","pub_time":1721620800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"FDIT","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004990/0001683168-24-004990-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"AMENDMENT TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004990/bioregenx_sc13da-libertas.htm","primary":true,"translateUrl":"","linkName":"bioregenx_sc13da-libertas.htm","type":"SC 13D/A","id":"NTFILE9WM5eN1TGNhQG3i1","market":"us","size":52920}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-07-22 12:00","pubTimestamp":1721620800,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18532464","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004970-FDIT","pdf_url":"","pub_time":1721435669000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"FDIT","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-004970-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004970/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHV2ZjJhiMwmMSCjQ","market":"us","size":7382}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-07-20 08:34","pubTimestamp":1721435669,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18532447","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004966-FDIT","pdf_url":"","pub_time":1721434611000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"FDIT","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-004966-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004966/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDbiWWNfTuMA1e1Cf","market":"us","size":7428}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-07-20 08:16","pubTimestamp":1721434611,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18389069","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004969-FDIT","pdf_url":"","pub_time":1721361600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"FDIT","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004969/0001683168-24-004969-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"AMENDMENT TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004969/bioregenx_sc13da-jara.htm","primary":true,"translateUrl":"","linkName":"bioregenx_sc13da-jara.htm","type":"SC 13D/A","id":"NTFILEFb1oeiEg6bm6baSB","market":"us","size":54495}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-07-19 12:00","pubTimestamp":1721361600,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18389065","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004965-FDIT","pdf_url":"","pub_time":1721361600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"FDIT","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004965/0001683168-24-004965-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"AMENDMENT TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004965/bioregenx_sc13da-wilshire.htm","primary":true,"translateUrl":"","linkName":"bioregenx_sc13da-wilshire.htm","type":"SC 13D/A","id":"NTFILE8d8ceyWoCtowLs9E","market":"us","size":43468}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-07-19 12:00","pubTimestamp":1721361600,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18373416","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004835-FDIT","pdf_url":"","pub_time":1721016000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"FDIT","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004835/0001683168-24-004835-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004835/bioregenx_8k.htm","primary":true,"translateUrl":"","linkName":"bioregenx_8k.htm","type":"8-K","id":"NTFILE5Sta8fPUBP4jZzt6","market":"us","size":18696}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-07-15 12:00","pubTimestamp":1721016000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18260105","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824004095-FDIT","pdf_url":"","pub_time":1718060021000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"FDIT","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-004095-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant\\'s Certifying Accountant;\nItem 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/bioregenx_8k.htm","primary":true,"translateUrl":"","linkName":"bioregenx_8k.htm","type":"8-K","id":"NTFILEFiaoTPb31dy7cgyL","market":"us","size":22066}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-06-11 06:53","pubTimestamp":1718060021,"title_zh":"Form 8-K - Current report","summary_en":"Item 4.01: Changes in Registrant\\'s Certifying Accountant;\nItem 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18206794","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824003858-FDIT","pdf_url":"","pub_time":1716939122000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]","symbol":"FDIT","title":"Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]","titleType":"[Rev.]Quaterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-003858-index.html","us_notice_code":"Form 10-Q/A","us_title_en":"Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM 10-Q/A FOR MARCH 2024","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003858/bioregenx_i10qa-033124.htm","primary":true,"translateUrl":"","linkName":"bioregenx_i10qa-033124.htm","type":"10-Q/A","id":"NTFILEGXgvtaSx8cjEx2Wr","market":"us","size":626089},{"description":"302 CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003858/bioregenx_ex3100.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex3100.htm","type":"EX-31","id":"NTFILE4PuwnFaJ9GTa6sMP","market":"us","size":6991},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003858/bioregenx_ex3200.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex3200.htm","type":"EX-32","id":"NTFILEZ4HK6cxvZ8VDoraz","market":"us","size":3037}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Quaterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[Rev.]Quaterly Report","pubTime":"2024-05-29 07:32","pubTimestamp":1716939122,"title_zh":"Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18192154","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824003807-FDIT","pdf_url":"","pub_time":1716523200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"FDIT","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003807/0001683168-24-003807-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003807/bioregenx_10q-033124.htm","primary":true,"translateUrl":"","linkName":"bioregenx_10q-033124.htm","type":"10-Q","id":"NTFILE8nRuK56bwBCnFq4c","market":"us","size":366358},{"description":"302 CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003807/bioregenx_ex3100.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex3100.htm","type":"EX-31","id":"NTFILEGiiqikAazfGCRSkF","market":"us","size":6769},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003807/bioregenx_ex3200.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex3200.htm","type":"EX-32","id":"NTFILE7uXqZXbW9XUiX9HX","market":"us","size":2742}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2024-05-24 12:00","pubTimestamp":1716523200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18154958","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824003582-FDIT","pdf_url":"","pub_time":1715832000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"FDIT","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003582/0001683168-24-003582-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824003582/bioregenx_8k.htm","primary":true,"translateUrl":"","linkName":"bioregenx_8k.htm","type":"8-K","id":"NTFILEBqAENBWp5gwVjptH","market":"us","size":20723}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-05-16 12:00","pubTimestamp":1715832000,"title_zh":"Form 8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18076972","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824002819-FDIT","pdf_url":"","pub_time":1714363200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General statement of acquisition of beneficial ownership","symbol":"FDIT","title":"Form SC 13D - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002819/0001683168-24-002819-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002819/bioregenx_jara.htm","primary":true,"translateUrl":"","linkName":"bioregenx_jara.htm","type":"SC 13D","id":"NTFILE7uYiozeNECPy7yu8","market":"us","size":53765}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-04-29 12:00","pubTimestamp":1714363200,"title_zh":"Form SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18076944","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824002817-FDIT","pdf_url":"","pub_time":1714363200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","symbol":"FDIT","title":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002817/0001683168-24-002817-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002817/bioregenx_libertas.htm","primary":true,"translateUrl":"","linkName":"bioregenx_libertas.htm","type":"SC 13D/A","id":"NTFILE6P9UKed7gDteozYt","market":"us","size":67487}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-04-29 12:00","pubTimestamp":1714363200,"title_zh":"Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18076652","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824002814-FDIT","pdf_url":"","pub_time":1714363200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General statement of acquisition of beneficial ownership","symbol":"FDIT","title":"Form SC 13D - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002814/0001683168-24-002814-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002814/bioregenx_wilshire.htm","primary":true,"translateUrl":"","linkName":"bioregenx_wilshire.htm","type":"SC 13D","id":"NTFILEBpnSZt3pVU6Qb8jU","market":"us","size":53282}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-04-29 12:00","pubTimestamp":1714363200,"title_zh":"Form SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18076566","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824002811-FDIT","pdf_url":"","pub_time":1714363200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General statement of acquisition of beneficial ownership","symbol":"FDIT","title":"Form SC 13D - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002811/0001683168-24-002811-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002811/bioregenx_libertas.htm","primary":true,"translateUrl":"","linkName":"bioregenx_libertas.htm","type":"SC 13D","id":"NTFILE9aYNYWmWg1x2n6ET","market":"us","size":66532}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-04-29 12:00","pubTimestamp":1714363200,"title_zh":"Form SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17882484","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824002317-FDIT","pdf_url":"","pub_time":1712894400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"FDIT","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002317/0001683168-24-002317-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"FORM 10-K FOR 12-31-23","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002317/bioregenx_i10k-123123.htm","primary":true,"translateUrl":"","linkName":"bioregenx_i10k-123123.htm","type":"10-K","id":"NTFILEDWpfWdszagmYU1MV","market":"us","size":567881},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002317/bioregenx_ex3100.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex3100.htm","type":"EX-31","id":"NTFILEFtV25H54GzuUhc5w","market":"us","size":13915},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824002317/bioregenx_ex3200.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex3200.htm","type":"EX-32","id":"NTFILEBTXyZ3f8JE5Bf38m","market":"us","size":5183}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2024-04-12 12:00","pubTimestamp":1712894400,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17805640","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824001917-FDIT","pdf_url":"","pub_time":1711752688000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"FDIT","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-001917-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.01: Completion of Acquisition or Disposition of Assets;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ARTICLES OF MERGER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenx_ex0305.htm","primary":true,"translateUrl":"","linkName":"bioregenx_ex0305.htm","type":"EX-3.5","id":"NTFILE8bCyazabc225EEDL","market":"us","size":11935},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenx_8k.htm","primary":false,"translateUrl":"","linkName":"bioregenx_8k.htm","type":"8-K","id":"NTFILEG5MxkhcPpLMt5Ygr","market":"us","size":30958},{"description":"AMENDMENT TO THE ARTICLES OF INCORPORATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenx_ex0306.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex0306.htm","type":"EX-3.6","id":"NTFILE8QXL28fnGuSToY8r","market":"us","size":6101},{"description":"CERTIFICATE OF DESIGNATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenx_ex0307.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex0307.htm","type":"EX-3.7","id":"NTFILECNyUJEjMEiwh3uVB","market":"us","size":4076},{"description":"CERTIFICATE OF CORRECTION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenx_ex0308.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex0308.htm","type":"EX-3.8","id":"NTFILEDhMMeyQ4sNTST5YS","market":"us","size":893},{"description":"PRESS RELEASE DATED MARCH 14, 2024","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenx_ex9902.htm","primary":false,"translateUrl":"","linkName":"bioregenx_ex9902.htm","type":"EX-99.2","id":"NTFILE3QwS8UE6bra6f14G","market":"us","size":11811},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/bioregenxlogo.jpg","primary":false,"translateUrl":"","linkName":"bioregenxlogo.jpg","type":"GRAPHIC","id":"NTFILEDjZVn6dRmpCEsCe8","market":"us","size":15438},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE3Ym9Ak7xJxkUm2vF","market":"us","size":754032},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_005.jpg","primary":false,"translateUrl":"","linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILEq5mzuqDwVApUMvyf","market":"us","size":1009924},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_006.jpg","primary":false,"translateUrl":"","linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILE7Y8F7HZv93L8FVSV","market":"us","size":541593},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_010.jpg","primary":false,"translateUrl":"","linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILE4cw15ZoeVpVVZtME","market":"us","size":786006},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_011.jpg","primary":false,"translateUrl":"","linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILE7ov2eX9E8GDR29a1","market":"us","size":665861},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_012.jpg","primary":false,"translateUrl":"","linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILEFSKGVGFjkyDEyVj4","market":"us","size":285763},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_018.jpg","primary":false,"translateUrl":"","linkName":"image_018.jpg","type":"GRAPHIC","id":"NTFILE3dJSoRWMwn9Jdh8v","market":"us","size":333766},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_019.jpg","primary":false,"translateUrl":"","linkName":"image_019.jpg","type":"GRAPHIC","id":"NTFILEAohmcU2RAcc9wsAd","market":"us","size":296383},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_020.jpg","primary":false,"translateUrl":"","linkName":"image_020.jpg","type":"GRAPHIC","id":"NTFILE6LjyENEE8G91FJYZ","market":"us","size":296621},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824001917/image_021.jpg","primary":false,"translateUrl":"","linkName":"image_021.jpg","type":"GRAPHIC","id":"NTFILE6N6M4V3ZV9uR8Ftq","market":"us","size":288012}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-03-30 06:51","pubTimestamp":1711752688,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.01: Completion of Acquisition or Disposition of Assets;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17593204","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824000287-FDIT","pdf_url":"","pub_time":1705411870000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"FDIT","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-000287-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824000287/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHpCvZSp374izciFs","market":"us","size":6886}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-01-16 21:31","pubTimestamp":1705411870,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17593602","market":"us","labels":[],"media":"sec.gov","original_id":"AN168316824000036-FDIT","pdf_url":"","pub_time":1704301040000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"FDIT","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1593184/0001683168-24-000036-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824000036/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEvcagVr1tVB1w7RtM","market":"us","size":10913}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-01-04 00:57","pubTimestamp":1704301040,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}